News Daily News Recent Stroke Heightens Risk of Perioperative Events After AVR Todd Neale April 25, 2018
News Daily News FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests Todd Neale April 11, 2018
News Conference News CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin Michael O'Riordan March 16, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018
News Daily News Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD Todd Neale January 19, 2017
News Daily News Blood Pressures Measured at Home Better Predict CAD Events Than Do Clinic Readings Todd Neale March 29, 2016
News Daily News Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure Michael O'Riordan January 19, 2016
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015
News Daily News Many Patients Referred for Renal Denervation Improve with Medication Adjustment May 12, 2014
News Daily News Mortality Benefit with ACE Inhibitors in Nonobstructive CAD L.A. McKeown March 20, 2014
News Conference News AHA 2013 Long-term Outcomes with Renal Denervation Show Sustained Benefit Yael L. Maxwell November 16, 2013
News Conference News ESC 2013 AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction Caitlin E. Cox September 04, 2013
News Daily News Meta-analysis: Heart Failure Worsens Short-term Prognosis of NSTE-ACS Patients June 28, 2013
News Daily News Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist Jason Kahn March 05, 2012